Zhiyi Biotechnology Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 83

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 11

Zhiyi Biotechnology General Information

Description

Developer of live biotherapeutics designed to advance microbiome-based drug discovery and treatment development. The company offers research microbial cultures and strains to develop effective treatments, is focused on unmet medical needs, and is dedicated to developing accessible drugs to benefit more patients, enabling healthcare professionals to prescribe better medicine.

Contact Information

Website
zypharm.com.cn
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 301, Building A
  • Number 2 Ruitai Road, Guangzhou High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510530
  • China
+86 020
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Room 301, Building A
  • Number 2 Ruitai Road, Guangzhou High-tech Industrial Development Zone
  • Guangzhou, Guangdong 510530
  • China
+86 020

Zhiyi Biotechnology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zhiyi Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. IPO 18-Jun-2026 Announced Clinical Trials - Phase 3
9. Later Stage VC (Series C3) 31-Mar-2026 Completed Clinical Trials - Phase 3
8. Later Stage VC (Series C2) 23-Jul-2024 Completed Clinical Trials - Phase 3
7. Later Stage VC (Series C1) 07-Apr-2024 Completed Clinical Trials - Phase 3
6. Later Stage VC (Series B3) 26-Jul-2022 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Private 09-Nov-2021 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B2) 22-Oct-2021 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series B1) 25-Dec-2020 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 06-Sep-2018 $7.3M $12.1M Completed Pre-Clinical Trials
1. Early Stage VC 09-Nov-2017 $4.83M $4.83M Completed Pre-Clinical Trials
To view Zhiyi Biotechnology’s complete valuation and funding history, request access »

Zhiyi Biotechnology Patents

  • 50

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Zhiyi Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024179462-A1 Use of bacteroides fragilis and extract capsular polysaccharide a thereof in preparation of product for preventing and treating autoimmune arthritis Inactive 27-Feb-2023
WO-2024022036-A1 Akkermansia muciniphila product for preventing and treating tumors and use thereof Inactive 29-Jul-2022
WO-2023237038-A1 Akkermansia muciniphila, use thereof, and culturing method therefor Inactive 08-Jun-2022
US-12453746-B2 Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome Active 08-Jun-2022
US-20250170187-A1 Use of akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome Active 08-Jun-2022 A61P3/00
To view Zhiyi Biotechnology’s complete patent history, request access »

Zhiyi Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zhiyi Biotechnology Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangdong Technology Financial Group Government Minority
Guangzhou Jinkong Fund Asset Manager Minority
Helichuangxing Group Corporation Minority
Qingshi Asset Management (Shanghai) Asset Manager Minority
Guoxin Sichuang Investment Fund Management Growth/Expansion Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Zhiyi Biotechnology FAQs

  • When was Zhiyi Biotechnology founded?

    Zhiyi Biotechnology was founded in 2013.

  • Where is Zhiyi Biotechnology headquartered?

    Zhiyi Biotechnology is headquartered in Guangzhou, China.

  • What is the size of Zhiyi Biotechnology?

    Zhiyi Biotechnology has 83 total employees.

  • What industry is Zhiyi Biotechnology in?

    Zhiyi Biotechnology’s primary industry is Drug Discovery.

  • Is Zhiyi Biotechnology a private or public company?

    Zhiyi Biotechnology is a Private company.

  • What is Zhiyi Biotechnology’s current revenue?

    The current revenue for Zhiyi Biotechnology is .

  • How much funding has Zhiyi Biotechnology raised over time?

    Zhiyi Biotechnology has raised $70.6M.

  • Who are Zhiyi Biotechnology’s investors?

    Guangdong Technology Financial Group, Guangzhou Jinkong Fund, Helichuangxing Group, Qingshi Asset Management (Shanghai), and Guoxin Sichuang Investment Fund Management are 5 of 11 investors who have invested in Zhiyi Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process